STK11 and melanoma: In contrast, ERK and ribosomal protein S6 kinase A (RSK), two downstream kinases of MAPK signaling, have been shown to phosphorylate and inhibit the upstream activator of AMPK, LKB1, and thus block the activation of AMPK by LKB1 in BRAFV600E-driven melanoma.